Related Experiment Video
Updated: Jul 9, 2026
04:42
Developing a Rat Model for Bipolar Disorder
Published on: May 2, 2025
[Genetic polymorphism of COMT in mental disorders]
Aneta Tylec1, Marta Stryjecka-Zimmer, Katarzyna Kucharska-Pietura
1Katedra i Klinika Psychiatrii AM w Lublinie.
Psychiatria Polska
|December 1, 2007
Summary
Genetic variations in the dopaminergic system, including enzymes like monoamine oxidase A (MAO-A) and catechol O-methyltransferase (COMT), are linked to mental health disorders. While not solely causing schizophrenia, these gene polymorphisms influence cognitive and emotional functions.
Area of Science:
- Neurobiology
- Genetics
- Psychiatry
Context:
- Dopaminergic neuropathways are implicated in the development of mental disorders.
- Genes regulating dopamine transmission, including receptors, transporters, and synthesis/degradation enzymes, are key areas of study.
- Specific gene polymorphisms, particularly in MAO-A and COMT, are associated with altered enzyme activity and various neuropsychiatric conditions.
Purpose:
- To explore the role of genetic variations in dopaminergic pathways in the context of mental disorders.
- To highlight the significance of functional polymorphisms in genes like MAO-A and COMT.
- To review the association of these polymorphisms with a range of cognitive, affective, and behavioral outcomes.
Summary:
- Abnormalities in dopaminergic neurotransmission are central to the pathophysiology of many mental disorders.
- Genetic evaluation of the dopaminergic system encompasses receptors, dopamine transporter, and key enzymes (TH, DDC, MAO, COMT).
- Functional polymorphisms in genes such as MAO-A and COMT are linked to altered enzyme function and influence on cognitive, affective, and behavioral traits, though no single gene is pathognomonic for schizophrenia.
Impact:
- Understanding these genetic links can inform diagnostic approaches and therapeutic strategies for mental health conditions.
- Highlights the complex interplay between genetics and neurobiology in psychiatric disorders.
- Provides a foundation for further research into gene-environment interactions affecting mental health.
Related Concept Videos
01:28Human Genetics
Human genetics provides a profound framework for understanding the interplay between genetic predispositions and human psychology. At the heart of this discipline lies the study of how genes influence physical traits, behaviors, and susceptibility to diseases. Each person carries a unique genetic code that subtly or significantly shapes their psychological and behavioral landscape.
The complex relationship between genetics and psychology is observable through common biological components such...
The complex relationship between genetics and psychology is observable through common biological components such...
01:29Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
01:27Pharmacogenetics of Drug Metabolism: Overview
Genetic polymorphism in drug metabolism is crucial to the inter-individual variability observed in drug responses. Drug metabolism primarily involves the chemical modification of drugs and other xenobiotics to enhance their elimination by increasing their polarity. Two main classes of enzymes mediate this biotransformation process: Phase I enzymes, primarily cytochrome P450s, catalyze oxidation and reduction reactions, while other enzymes, such as esterases, mediate hydrolysis, and Phase II...
01:27Principles of Pharmacogenetics: Types of Genetic Variants
The human genome is over 99.9% identical between individuals, yet genetic differences exist at millions of bases. The human genome contains approximately 3 million variant positions per individual, many of which are heterozygous, contributing to genetic diversity and individual traits. Genetic variations include single-nucleotide polymorphisms (SNPs), insertions, deletions, and copy number variations (CNVs).SNPs, the most common variation, involve single-base changes in DNA. These can be...
01:11Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
01:28Pharmacogenetics of Phase I Enzymes: Cytochrome P450 Isozymes
Cytochrome P450 (CYP450) enzymes are a superfamily of heme-containing monooxygenases that play a pivotal role in Phase I drug metabolism by catalyzing oxidation and reduction reactions.These enzymes transform lipophilic xenobiotics into more hydrophilic metabolites, facilitating subsequent Phase II conjugation and eventual excretion. The CYP450 family is classified into families (e.g., CYP1–CYP3) and subfamilies (e.g., CYP2A, CYP2C), based on amino acid sequence homology.CYP450 isoenzymes,...